Research Institute For Endocrine Sciences 1
1. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
2. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
3. Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight
4. Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
5. Diminishing benefits of urban living for children and adolescents’ growth and development
6. Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
7. Global mortality from dementia: Application of a newmethod and results from the global burden of disease study 2019
8. Global estimates on the number of people blind or visually impaired by cataract: a meta-analysis from 2000 to 2020
9. Mapping routine measles vaccination in low- and middle-income countries
10. The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019
11. General and abdominal adiposity and hypertension in eight world regions: a pooled analysis of 837 population-based studies with 7·5 million participants
12. Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c
13. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants
1